Sunitinib malate is approved to treat adults with: Gastrointestinal stromal tumor (a type of stomach cancer). It is used in patients whose condition has become worse while taking imatinib mesylate or who are not able to take it. Pancreatic cancer.
Sunitinib malate is approved to treat adults with: Gastrointestinal stromal tumor (a type of stomach cancer). It is used in patients whose condition has become worse while taking imatinib mesylate or who are not able to take it. Pancreatic cancer.